Products & Tech | Page 58 of 63

Abbott Receives FDA Clearance for New Easier-to-Use Test Strips

Abbott announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new FreeStyle Lite blood glucose test strips. The new FreeStyle Lite test strips minimize interference during blood glucose testing and are designed to offer...

The Quest for a Robotic Pancreas

The artificial pancreas is no longer the jet pack of diabetes, talked about for decades without ever coming to fruition...

Diabetes Drug Metformin Linked to Vitamin B 12 Deficiency

Diabetics treated over long periods with the drug metformin, one of the most commonly prescribed drugs for the treatment of diabetes, are at risk of developing vitamin B12 deficiency. This condition is likely to get worse over time, according to a study published in the British Medical Journal...

Avandia Settlements: Glaxo Agrees to Pay $60 Million

GlaxoSmithKline Plc agreed to pay about $60 million in the first settlements of lawsuits alleging the company’s Avandia diabetes drug causes heart attacks and strokes in some users, according to a Bloomberg report...

FDA Classifies Bydureon Complete Response as a Class 2 Resubmission

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. announced that the U.S. Food and Drug Administration has classified the Bydureon(TM) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010...

Novo Nordisk Anounces Victoza Cardiovascular Outcomes Trial

Novo Nordisk (NVO) announced today details of the company's cardiovascular outcomes trial for Victoza® (liraglutide [rDNA origin] injection), which is set to start in the autumn of 2010. The trial named LEADE aims to assess and confirm the cardiovascular safety of the company's new once-daily human GLP-1 analog Victoza...

Where Have You Flexed?

Novo Nordisk has announced an online insulin pen photo contest. The "Where Have You Flexed?" contest asks people who use the FlexPen to submit photos of themselves with their pen in unique locations. The grand prize winner will receive a trip for two to the Firestone Indy Lights championship in Miami on October 2 to see Charlie Kimball...

Bayer Introduces Nintendo Compatible Glucose Monitor in the US

Bayer Diabetes Care announced the introduction of the DIDGET™ blood glucose monitoring system in the United States. The Didget meter is unique because it is the only blood glucose meter that connects directly to Nintendo DS™ and DS Lite gaming systems to help kids manage a lifelong disease...

Study Shows AFREZZA Safe and Effective in Controlling Blood Glucose Levels

MannKind Corp. announced the results of a two year study comparing the efficacy and safety of AFREZZA (insulin human [rDNA origin]) versus usual diabetes care. The study followed patients for a total of up to two years. The patients were randomly assigned to a treatment regimen of either AFREZZA plus...

Superior Efficacy of Victoza Compared to Januvia in the Treatment of Type 2 Diabetes

Novo Nordisk's new diabetes drug Victoza proved more effective than Merck & Co's Januvia in a head-to-head study published, in the Lancet. The 26-week trial showed that Victoza produced significantly greater reductions in HbA1C, fasting plasma glucose and body weight than Januvia, with similar or better overall treatment satisfaction....